Epidemiology of first and recurrent venous thromboembolism: a population-based cohort study in patients without active cancer.

@article{Martinez2014EpidemiologyOF,
  title={Epidemiology of first and recurrent venous thromboembolism: a population-based cohort study in patients without active cancer.},
  author={Carlos Martinez and Alexander T. Cohen and Luke Bamber and Stephan Rietbrock},
  journal={Thrombosis and haemostasis},
  year={2014},
  volume={112 2},
  pages={
          255-63
        }
}
Contemporary data from population studies on the incidence and complications of venous thromboembolism (VTE) are limited. An observational cohort study was undertaken to estimate the incidence of first and recurrent VTE. The cohort was identified from all patients in the UK Clinical Practice Research Datalink (CPRD) with additional linked information on hospitalisation and cause of death. Between 2001 and 2011, patients with first VTE were identified and the subset without active cancer-related… 

Figures and Tables from this paper

Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. A population-based cohort study.
TLDR
An observational cohort study was undertaken to estimate the incidence of first and recurrent venous thromboembolism in patients with active cancer, finding rates were similar after initial pulmonary embolism and after initial deep-vein thrombosis.
A Population-Based Perspective onClinically Recognized Venous Thromboembolism:Contemporary Trends in Clinical Epidemiology andRisk Assessment of Recurrent Events: A Dissertation
TLDR
Examining recent trends in the epidemiology of clinically recognized VTE among residents of the Worcester, Massachusetts, metropolitan statistical area from 1985 through 2009 found that non-invasive diagnostic VTE testing increased, and the risk of recurrence after a first acute episode of VTE was assessed.
Occurrence and predictors of recurrence after a first episode of acute venous thromboembolism: population-based Worcester Venous Thromboembolism Study
TLDR
The rate of VTE recurrence over 3 years of follow-up remained high, and the risk score calculator may assist clinicians at the index encounter in determining the frequency of clinical surveillance and appropriate outpatient treatment of V TE during the acute treatment phase.
Venous Thromboembolism Recurrence in Latvian Population: Single University Hospital Data
TLDR
Patients who experienced recurrent VTE had 6.6-fold higher mortality rate than patients with no recurrences, and the presence of active cancer was not a statistically significant risk factor for recurrence when taking into account the competing risk of death.
The management of acute venous thromboembolism in clinical practice.
TLDR
In conclusion, PREFER in VTE has provided contemporary insights into VTE patients and their real-world management, including their baseline characteristics, risk factors, disease history, symptoms and signs, initial therapy and outcomes.
The management of acute venous thromboembolism in clinical practice
TLDR
In conclusion, PREFER in VTE has provided contemporary insights into VTE patients and their real-world management, including their baseline characteristics, risk factors, disease history, symptoms and signs, initial therapy and outcomes.
Bidirectional risk between venous thromboembolism and cancer in East Asian patients: synthesis of evidence from recent population-based epidemiological studies
  • V. C. Kok
  • Medicine
    Cancer management and research
  • 2017
TLDR
Similar to the trend in VTE incidence among the general population, VTE risk in East Asian cancer patients is markedly lessened.
Incidence and risk factors of chronic thromboembolic pulmonary hypertension following venous thromboembolism, a population-based cohort study in England
TLDR
The aim of this study was to estimate the incidence and risk factors of CTEPH in a cohort with first venous thromboembolism (VTE), a population-based cohort study of patients with first VTE and no active cancer in England between 2001 and 2012.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 20 REFERENCES
Incidence rates, clinical profile, and outcomes of patients with venous thromboembolism. The Worcester VTE study
TLDR
The data suggest that while the incidence rates of VTE remain high, and outcomes suboptimal, there have been marked changes in its management.
Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom.
TLDR
Overweight, varicose veins, cancer, inflammatory bowel disease, fractures, surgery, and use of oral corticosteroids, oral contraceptives, and opposed hormone therapy were independent risk factors for both DVT and PE.
Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality.
TLDR
The estimated total number of symptomatic VTE events (range based on probabilistic sensitivity analysis) per annum within the six EU countries was 465,715; almost three-quarters of all VTE-related deaths were from hospital-acquired VTE.
Validation of the diagnosis of venous thromboembolism in general practice database studies.
TLDR
The GPRD provides information of sufficiently high quality to allow valid epidemiological research of VTE events, and excluding cases without a database record of hospital admission would lead to valid events being overlooked, and an under-estimate of the disease incidence.
Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis
TLDR
In patients with a first unprovoked venous thromboembolism, men have a 2.2-fold higher risk of recurrent venousThromboEmbolism than do women, and the risk of recurrence remains 1.8-foldHigher in men after adjustment for previous hormone associated venous Thrombo Embolism in women.
Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study.
TLDR
Estimating the population attributable risk (defined as the percentage of all cases of a disease in a population that can be "attributed" to a risk factor) for deep vein thrombosis and pulmonary embolism associated with venous thromboembolism risk factors suggests greater emphasis should be placed on prophylaxis for hospitalized medical patients.
Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study.
TLDR
The incidence of pulmonary embolism has decreased over time, the incidence of deep vein thrombosis remains unchanged for men and is increasing for older women, and the need for more accurate identification of patients at risk for venous thromboembolism is emphasized.
The epidemiology of venous thromboembolism in the community.
TLDR
To reduce venous thromboembolism incidence, improve survival, and prevent recurrence and complications, patients with these characteristics should receive appropriate prophylaxis.
Incidence of venous thromboembolism verified by necropsy over 30 years.
TLDR
The overall incidence of venous thromboembolism has not changed over 30 years, and the proportion of the population aged over 65 has doubled, and this may have masked the beneficial effects of prophylaxis and early mobilisation.
...
1
2
...